This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim (Canada) Ltd.. Active years: 2008-2011.
Company Filing History:
3 out of 1,561 
1 out of 62 
Years Active: 2008-2011
Title: Josee Bordeleau: A Pioneer in Innovation and Technology
Introduction:
Josee Bordeleau, a visionary inventor hailing from Laval, CA, is a true trailblazer in the world of inventions. With a profound passion for innovation and a relentless drive to create a better future through technology, he has left an indelible mark in the realm of patents and inventions.
Latest Patents:
Josee Bordeleau's latest patents revolve around groundbreaking Hepatitis C inhibitor compounds. These compounds, defined by formula (I), have shown great promise as inhibitors of HCV NS3 protease for the treatment of Hepatitis C viral infection. With a total of 4 patents to his name, Bordeleau continues to push the boundaries of medical innovation.
Career Highlights:
Having worked with esteemed companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim (Canada) Ltd., Josee Bordeleau has amassed a wealth of experience in the pharmaceutical and biotech industries. His innovative spirit and knack for creating cutting-edge solutions have garnered him recognition as a top-tier inventor.
Collaborations:
Throughout his career, Josee Bordeleau has collaborated with industry peers such as Jean Rancourt and Montse Llinas-Brunet. Together, they have brought forth innovative ideas and transformative technologies that have the potential to shape the future of healthcare and beyond.
Conclusion:
In conclusion, Josee Bordeleau stands as a shining example of a true pioneer in the world of inventions. His passion for innovation, coupled with his unwavering dedication to creating a better future through technology, sets him apart as a visionary inventor whose impact will be felt for years to come.